The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -23.50%.However, over the last six months, we can see a stronger performance of -19.50%. Over the last 30 days, the price of RXRX has fallen by 9.16%. And in the last five days, it has fallen by -8.79%.
Recursion Pharmaceuticals Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $15.74 on 02/27/24 and a low of $5.60 for the same time frame on 11/22/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of RXRX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Recursion Pharmaceuticals Inc’s current trading price is -52.08% away from its 52-week high, while its distance from the 52-week low is 34.70%. The stock’s price range during this period has varied between$5.60 and $15.74. The Recursion Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 11.25 million for the day, a figure considerably higher than their average daily volume of 8.18 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly rise of 11.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.92B.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.80, with a change in price of -0.58. Similarly, Recursion Pharmaceuticals Inc recorded 7,095,674 in trading volume during the last 100 days, posting a change of -7.20%.
RXRX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.14.
RXRX Stock Stochastic Average
As of today, Recursion Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 47.34%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 47.34%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 38.82% and 40.82%, respectively.
